In summary, this study demonstrates that serum NOTCH3-ECD is a sensitive and specific biomarker for IPAH, with the ability to accurately and noninvasively detect disease presence, severity and survival. Here, NOTCH3 is linked to idiopathic pulmonary arterial hypertension.